Focus on cardiac at Holmesglen Private Hospital

The cardiology team at Holmesglen Private Hospital have recently expanded their service offering the latest medical technology to help discover, diagnose and treat potentially lethal cardiac conditions, that otherwise go unseen.

Emma Caltabiano never thought that a fainting episode would save her life, but it did.

During a shopping trip with her husband Alfie, Emma passed out., se was rushed to hospital where she received a CT scan on her brain and was observed for five hours before being sent home.

A week later Emma had another fainting episode. She was sitting on the couch with a coffee before standing up and passing out. This time she was alone – fortunately Alfie wasn’t too far away.

An Ambulance took Emma to Holmesglen Private Hospital where doctors performed a blood test, monitored her and ElectroPhysiologist Dr Emily Kotschet provided care. Dr Kotschet recommended the use of an insertable cardiac monitor. Emma received a Reveal LINQ device the next day.

Insertable heart monitors are designed to help physicians quickly and accurately diagnose irregular, and potentially lethal, heartbeats.

Reveal LINQ is about one third of the size of an AAA battery however it has the same battery life, and more data memory, than other heart monitors. The device continuously and wirelessly monitor a patient’s heart for up to three years, and sends information to a patient’s physician to help them make an accurate diagnosis and determine a treatment plan.

Within one week, Emma’s device identified an abnormality.

“I was at home when I received a call asking whether I was ok. I thought I was but the cardiac team monitoring my device said I needed to visit the Emergency Department," said Emma.

Dr Kotschet, explains that detecting underlying heart rhythm conditions is the first step to improving health outcomes.

"As symptoms can be infrequent and unexpected, the effectiveness of short-term investigative tools such as 24 hour holter monitors or time-consuming hospital surveillance visits are limited. Insertable cardiac monitoring, and the associated monitoring service provides peace of mind to patients, and meaningful information for healthcare teams," said Dr Kotschet.

After arriving at Holmesglen Emma was admitted and received an Implantable Cardioverter Device [ICD]. Like the heart monitor, this observes the rhythm of the heart; however instead of altering someone to an abnormality it will activate and restore the rhythm of the heart automatically.

Since receiving her device, Emma has returned twice for check-ups, on both occasions, the cardiac team had detected cardiac events where the ICD saved Emma’s life.